Aldeyra Therapeutics Statistics
Total Valuation
ALDX has a market cap or net worth of $101.94 million. The enterprise value is $53.66 million.
Important Dates
The last earnings date was Thursday, May 7, 2026, after market close.
| Earnings Date | May 7, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ALDX has 60.32 million shares outstanding. The number of shares has increased by 0.94% in one year.
| Current Share Class | 60.32M |
| Shares Outstanding | 60.32M |
| Shares Change (YoY) | +0.94% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 3.25% |
| Owned by Institutions (%) | 53.16% |
| Float | 48.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.45 |
| P/TBV Ratio | 2.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.37.
| Current Ratio | 2.72 |
| Quick Ratio | 2.67 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -15.01 |
Financial Efficiency
Return on equity (ROE) is -51.76% and return on invested capital (ROIC) is -25.93%.
| Return on Equity (ROE) | -51.76% |
| Return on Assets (ROA) | -22.22% |
| Return on Invested Capital (ROIC) | -25.93% |
| Return on Capital Employed (ROCE) | -67.33% |
| Weighted Average Cost of Capital (WACC) | 10.44% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.91M |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.43% in the last 52 weeks. The beta is 1.15, so ALDX's price volatility has been higher than the market average.
| Beta (5Y) | 1.15 |
| 52-Week Price Change | -24.43% |
| 50-Day Moving Average | 2.24 |
| 200-Day Moving Average | 4.44 |
| Relative Strength Index (RSI) | 40.10 |
| Average Volume (20 Days) | 987,611 |
Short Selling Information
The latest short interest is 7.36 million, so 12.21% of the outstanding shares have been sold short.
| Short Interest | 7.36M |
| Short Previous Month | 5.54M |
| Short % of Shares Out | 12.21% |
| Short % of Float | 15.12% |
| Short Ratio (days to cover) | 4.36 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -28.38M |
| Pretax Income | -27.37M |
| Net Income | -27.37M |
| EBITDA | -28.13M |
| EBIT | -28.38M |
| Earnings Per Share (EPS) | -$0.45 |
Full Income Statement Balance Sheet
The company has $65.00 million in cash and $15.51 million in debt, with a net cash position of $49.49 million or $0.82 per share.
| Cash & Cash Equivalents | 65.00M |
| Total Debt | 15.51M |
| Net Cash | 49.49M |
| Net Cash Per Share | $0.82 |
| Equity (Book Value) | 42.16M |
| Book Value Per Share | 0.70 |
| Working Capital | 41.95M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -25.99M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 257,680 |
| Net Borrowing | n/a |
| Free Cash Flow | -25.99M |
| FCF Per Share | -$0.43 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALDX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.94% |
| Shareholder Yield | -0.94% |
| Earnings Yield | -26.53% |
| FCF Yield | -25.19% |
Analyst Forecast
The average price target for ALDX is $5.50, which is 225.44% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.50 |
| Price Target Difference | 225.44% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |